Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis.
Deveaux V, Cadoudal T, Ichigotani Y, Teixeira-Clerc F, Louvet A, Manin S, Nhieu JT, Belot MP, Zimmer A, Even P, Cani PD, Knauf C, Burcelin R, Bertola A, Le Marchand-Brustel Y, Gual P, Mallat A, Lotersztajn S.
Deveaux V, et al. Among authors: nhieu jt.
PLoS One. 2009 Jun 9;4(6):e5844. doi: 10.1371/journal.pone.0005844.
PLoS One. 2009.
PMID: 19513120
Free PMC article.